Skip to content

Impacts of Oxycodone Hydrochloride on Tracheal intubation Tolerance during Recovery

Impacts of Oxycodone Hydrochloride on Tracheal intubation Tolerance during Recovery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040370
Enrollment
Unknown
Registered
2020-11-28
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Anesthesia

Interventions

one:oxycodone hydrochloride 5mg
two:same dose of normal saline

Sponsors

Wuxi 9th Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18 to 65 years old; 2) Perform elective surgery (for tracheal intubation and mechanical ventilation); 3) ASA score is II-III level; 4) BMI 30 kg/m2 to 40kg/m2; 5) Clearly understand and voluntarily participate in the research, and the informed consent form should be signed.

Exclusion criteria

Exclusion criteria: 1) Emergency surgery; hypovolemia, shock or coma; 2) In addition to general intravenous anesthesia, other anesthesia methods, such as inhalation anesthesia, rigid extra-membrane and subarachnoid anesthesia, etc.; 3) Infectious heart diseases such as myocarditis or endocarditis; sepsis; 4) Uncontrolled hypertension, diabetes, heart failure, etc.; 5) Abnormal liver function, AST and/or ALT>=2.5 ULN, TBIL>=1.5 ULN; 6) Abnormal renal function, urea or urea nitrogen >=1.5 ULN, and blood creatinine greater than the upper limit of normal; 7) Suffer from mental system diseases (schizophrenia, mania, bipolar disorder, mental disorder Etc.) and those with long-term history of taking psychotropic drugs and cognitive impairment; 8) Women who are pregnant or breastfeeding; 9) Those who are allergic or contraindicated to benzodiazepines, opioids, propofol, muscle relaxants and other drugs and their drug components; 10) Other situations where the researcher thinks it is inappropriate to participate in this trial.

Design outcomes

Primary

MeasureTime frame
blood pressure;heart rate;recovery time;epinephrine, norepinephrine;the cough;

Secondary

MeasureTime frame
sedation scores;

Countries

China

Contacts

Public ContactZhenqing Liu

Wuxi 9th Affiliated Hospital of Soochow University

liuzhenqing@21cn.com+86 13961824655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 22, 2026